MICHAEL (MICK) SOTH, Ph.D.

Mick Soth is the Institute Director of Medicinal Chemistry in the Therapeutics Discovery Division at MD Anderson Cancer Center. Formerly at Roche Pharmaceuticals and has led multiple drug discovery programs to development candidates in both the cancer and neurodegeneration fields, including a glutaminase-1 inhibitor currently in clinical trials.